Physician profile
Jamila Fox
NPI 1437765492
$3,602.27
in general payments reported to CMS, 2019-2025
16 companies · $971 in 2025
The $971 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $550 · 2022: $507 · 2023: $529 · 2024: $1,045 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,544.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,058.84 | 2022-2025 | |
| Gilead Sciences, INC. | $818.20 | 2021-2025 | Biktarvy, Vemlidy, Sunlenca |
| Boehringer Ingelheim Pharmaceuticals, INC. | $543.90 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $223.08 | 2023-2025 | Caplyta |
| Glaxosmithkline, LLC. | $213.28 | 2022-2025 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $208.69 | 2024-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $112.22 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Axsome Therapeutics, INC. | $69.59 | 2023-2025 | Auvelity |
| Novo Nordisk INC | $65.64 | 2025 | Wegovy, Saxenda |
| Lilly USA, LLC | $63.31 | 2021-2025 | Mounjaro |
| Lundbeck LLC | $50.60 | 2025 | Rexulti |
| Cipher Pharmaceuticals US LLC | $48.77 | 2025 | Natroba, Spinosad |
| Pfizer INC. | $39.19 | 2025 | |
| Exact Sciences Corporation | $37.75 | 2025 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $30.26 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qiagen, LLC | $18.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamila Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.